Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin I W Galasko

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Heart Failure|June 12, 2003
The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniquesGavin I W Galasko, Avijit Lahiri
The International Journal of Cardiovascular Imaging|December 24, 2005
Direct access echocardiographyGavin I W Galasko, Michael Henein
Clinical Medicine (London, England)|July 20, 2007
Acute cardiovascular medicineGavin I W Galasko, Chris S R Baker
European Heart Journal|July 26, 2005
What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?Gavin I W Galasko, Avijit Lahiri, Sophie C Barnes, et al.
European Heart Journal|November 4, 2005
What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?Gavin I W Galasko, Sophie C Barnes, Paul Collinson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Heart Failure|June 12, 2003
The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniquesGavin I W Galasko, Avijit Lahiri
The International Journal of Cardiovascular Imaging|December 24, 2005
Direct access echocardiographyGavin I W Galasko, Michael Henein
Clinical Medicine (London, England)|July 20, 2007
Acute cardiovascular medicineGavin I W Galasko, Chris S R Baker
European Heart Journal|July 26, 2005
What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?Gavin I W Galasko, Avijit Lahiri, Sophie C Barnes, et al.
European Heart Journal|November 4, 2005
What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?Gavin I W Galasko, Sophie C Barnes, Paul Collinson, et al.
Pageof 1